Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative.

Cancer Prevention Research
V Craig Jordan

Abstract

The Women's Health Initiative (WHI) was designed to evaluate the benefits of hormone replacement therapy. The primary goal was to establish the value of synthetic progestin and estrogen or estrogen alone to reduce the risk of coronary heart disease (CHD). The estrogen/synthetic progestin trial was stopped at 5.2 years and the estrogen trial was stopped after 6.8 years. Although the estrogen/synthetic progestin trial was stopped for the anticipated rise in the risk of breast cancer, the estrogen trial was stopped for elevation of strokes. Women taking estrogen/synthetic progestin or estrogen alone had no benefit from a reduction in CHD. Paradoxically, there was a decrease in breast cancer incidence in the estrogen trial. The decrease in breast cancer was sustained. The elevation of breast cancer in the estrogen/synthetic progestin trial was also sustained a decade after stopping treatment. Evidence is presented to explain the paradoxical sustained decrease in breast cancer with estrogen and the mechanism for the reversal of breast cancer incidence and mortality with the mixed synthetic progestin/glucocorticoid actions of the synthetic progestin used with estrogen in women with an intact uterus. The fact that the WHI study had an...Continue Reading

References

Dec 4, 1975·The New England Journal of Medicine·H K Ziel, W D Finkle
Dec 4, 1975·The New England Journal of Medicine·D C SmithW L Herrmann
Dec 1, 1992·Molecular and Cellular Endocrinology·S Y JiangV C Jordan
Aug 1, 1987·European Journal of Cancer & Clinical Oncology·C K OsborneJ P Robinson
Sep 1, 1985·Environmental Health Perspectives·V C JordanM E Lieberman
Nov 1, 1973·Journal of the National Cancer Institute·H D SouleM Brennan
Jan 1, 1993·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·D M Wolf, V C Jordan
Mar 1, 1996·Nucleic Acids Research·J J PinkV C Jordan
Nov 22, 2001·Journal of the National Cancer Institute·R X SongR J Santen
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A HowellC Morris
Mar 4, 2003·Nature Reviews. Drug Discovery·V Craig Jordan
Nov 6, 2003·Journal of the National Cancer Institute·Hong LiuV Craig Jordan
Nov 6, 2003·Journal of the National Cancer Institute·Clodia OsipoV Craig Jordan
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
May 3, 2005·The Journal of Steroid Biochemistry and Molecular Biology·J S LewisV C Jordan
Dec 8, 2005·Journal of the National Cancer Institute·Joan S LewisV Craig Jordan
Jun 7, 2006·JAMA : the Journal of the American Medical Association·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project (NSABP)
Feb 22, 2007·Journal of the National Cancer Institute·Jack CuzickUNKNOWN International Breast Cancer Intervention Study I Investigators
Feb 22, 2007·Journal of the National Cancer Institute·Trevor J PowlesMitch Dowsett
Jun 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan
Mar 26, 2010·Journal of Medicinal Chemistry·Philipp Y MaximovV Craig Jordan
Apr 21, 2010·Cancer Prevention Research·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rowan T ChlebowskiMarcia L Stefanick
Sep 23, 1944·British Medical Journal·A HaddowP C Koller
Apr 7, 2011·JAMA : the Journal of the American Medical Association·Andrea Z LaCroixUNKNOWN WHI Investigators
Oct 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Eric A AriaziV Craig Jordan
Jun 5, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ping FanV Craig Jordan
Oct 16, 2012·Current Clinical Pharmacology·Philipp Y MaximovV Craig Jordan
Nov 5, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ping FanV Craig Jordan
Jun 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George W SledgeAntonio C Wolff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.